You're reading the free version. Trader adds the live tape and alerts.
Start tracking
VERA Sale Disclosure
Fordyce Marshall · SEC Form 4 · Filed Aug 12, 2026
Sale
Calculated transaction value
$520.98K
Fordyce Marshall President And CEO
VERA
Vera Therapeutics
VERA
Transaction date
May 12, 2026
Public filing date
Aug 12, 2026
Filing lag
Filed 92 days later
VERA daily price context
Close on/before transaction
$36.7
May 12, 2026
First close after public filing
$28.89
Aug 13, 2026
30-day return after filing
+21.32%
Through Sep 11, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Class A Common Stock
- Quantity / price
- 14,219 shares @ $36.64
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4/A
- Filing identifier
- 0001859453-26-000011
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$733.34K
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Vera Therapeutics, Inc. VERA | Exercise | May 12, 2026 | $53.59K |
| Vera Therapeutics, Inc. VERA Current | Sale | May 12, 2026 | $520.98K |
| Vera Therapeutics, Inc. VERA | Sale | May 12, 2026 | $158.77K |
| Vera Therapeutics, Inc. VERA | Exercise | May 12, 2026 | $0 |